Overview

Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the safety and tolerability of nebivolol and valsartan given as a free tablet combination in patient with stage 1 or stage 2 essential hypertension.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Hydrochlorothiazide
Nebivolol
Valsartan
Criteria
Inclusion Criteria:

- Male or female outpatients of age 18 years or above

- Patients diagnosed with stage 1 or stage 2 essential hypertension

- Normal physical examination findings, electrocardiogram (ECG) results and chest x-ray;
or abnormal findings judged by the Investigator to be not clinically significant

Exclusion Criteria:

- Secondary hypertension or severe hypertension

- Clinically significant cardiovascular disease or heart failure

- A medical contraindication to discontinuing a current antihypertensive therapy

- History of Type 1 diabetes mellitus